Blockbuster weight loss drugs like Wegovy and Zepbound have surged in popularity, but high prices have left them out of reach ...

UnitedHealth Group's pharmacy benefits manager, OptumRx Inc., was hit with an Employee Retirement Income Security Act of 1974 lawsuit for allegedly improperly approving more than $4.3 million for ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and ...

The Trump administration is planning a five-year test allowing states to cover weight-loss drugs like Ozempic and Wegovy ...

State Medicaid programs already are allowed to offer GLP-1 drugs for weight loss, but only 13 state programs currently do so.

Over half of large US employers plan to cut health benefits in 2026 as rising costs of weight-loss drugs like Wegovy drive up ...

rising prices are forcing a rethink. "Some employers facing big cost increases in 2026 may feel this coverage is out of reach," Fluno said. Greater competition in the weight-loss drug market in the ...

Cigna has sold its Medicare businesses and slashed the number of people it covers in its ACA plans by more than half.

Medicare and Medicaid move toward covering Ozempic and other weight loss drugs - The proposed plan could go into effect as early as next April for those on Medicaid ...

Among employers with 500 or more workers, 51% said they planned to increase cost-sharing in 2026, including raising deductibles and maximum out-of-pocket costs for workers ...

Full year 2025 pretax adjusted earnings outlooks for Evernorth and Cigna Healthcare remain at "at least $7.2 billion" and "at least $4.125 billion" respectively. The company expects the full year ...

The report, compiled for The New York Times by health analytics company Komodo Health, shows that denial rates rose from 18.3 ...